Long-term effects of peginterferon alfa-2a therapy in Japanese patients with chronic hepatitis B virus infection

BACKGROUND: There is no information on the long-term effects of peginterferon (PEG-IFN) alfa-2a therapy for chronic hepatitis B (CHB) in Japan. This double-blind, randomized trial investigated the efficacy of PEG-IFN therapy. METHODS: We analyzed 22 Japanese patients with CHB (hepatitis B e antigen...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Virol J
Hlavní autoři: Masaki, Keiichi, Suzuki, Fumitaka, Hara, Tasuku, Kawamura, Yusuke, Sezaki, Hitomi, Hosaka, Tetsuya, Akuta, Norio, Kobayashi, Masahiro, Saitoh, Satoshi, Suzuki, Yoshiyuki, Arase, Yasuji, Ikeda, Kenji, Kobayashi, Mariko, Kumada, Hiromitsu
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2015
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4690279/
https://ncbi.nlm.nih.gov/pubmed/26700861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12985-015-0453-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky